Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $22.8 million.

  • Beam Therapeutics' Amortizatization of Intangibles fell 24.72% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 31.94%. This contributed to the annual value of $22.8 million for FY2024, which is 23.46% down from last year.
  • Beam Therapeutics' Amortizatization of Intangibles amounted to $22.8 million in FY2024, which was down 23.46% from $29.7 million recorded in FY2023.
  • In the past 5 years, Beam Therapeutics' Amortizatization of Intangibles registered a high of $29.7 million during FY2023, and its lowest value of -$118,000 during FY2020.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $22.8 million (2024), whereas its average is $20.6 million.
  • As far as peak fluctuations go, Beam Therapeutics' Amortizatization of Intangibles plummeted by 112.83% in 2020, and later soared by 12,446.67% in 2022.
  • Yearly analysis of 5 years shows Beam Therapeutics' Amortizatization of Intangibles stood at -$118,000 in 2020, then spiked by 163.56% to $75,000 in 2021, then surged by 12,446.67% to $9.4 million in 2022, then soared by 216.08% to $29.7 million in 2023, then dropped by 23.46% to $22.8 million in 2024.